Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis - Authors' reply
Standard
Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis - Authors' reply. / Guttman-Yassky, Emma; Simpson, Eric L; Reich, Kristian; Kabashima, Kenji; Igawa, Ken; Suzuki, Tetsuya; Mano, Hirotaka; Matsui, Takeshi; Esfandiari, Ehsanollah; Furue, Masutaka.
in: LANCET, Jahrgang 402, Nr. 10415, 18.11.2023, S. 1834.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Kommentar › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis - Authors' reply
AU - Guttman-Yassky, Emma
AU - Simpson, Eric L
AU - Reich, Kristian
AU - Kabashima, Kenji
AU - Igawa, Ken
AU - Suzuki, Tetsuya
AU - Mano, Hirotaka
AU - Matsui, Takeshi
AU - Esfandiari, Ehsanollah
AU - Furue, Masutaka
PY - 2023/11/18
Y1 - 2023/11/18
KW - Humans
KW - Dermatitis, Atopic/drug therapy
KW - Severity of Illness Index
KW - Treatment Outcome
KW - Double-Blind Method
U2 - 10.1016/S0140-6736(23)01618-5
DO - 10.1016/S0140-6736(23)01618-5
M3 - Comment/debate
C2 - 37980090
VL - 402
SP - 1834
JO - LANCET
JF - LANCET
SN - 0140-6736
IS - 10415
ER -